Glucocorticoid-mediated inhibition of angiogenic changes in human endothelial cells is not caused by reductions in cell proliferation or migration

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Logie, James J ^a   Ali, Sadaf ^a   Marshall, Kathryn M ^a   Heck, Margarete M S ^a   Walker, Brian R ^a   Hadoke, Patrick W F ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; PROSTAGLANDIN F2 ALPHA; THROMBOSPONDIN 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; BROXURIDINE; COLLAGEN; LAMININ; MATRIGEL; MIFEPRISTONE; PROTEOGLYCAN;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MIGRATION INHIBITION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TIME LAPSE IMAGING; UMBILICAL VEIN ENDOTHELIAL CELL; AORTA; BIOSYNTHESIS; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG COMBINATION; ENDOTHELIUM CELL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN;

AORTA; BROMODEOXYURIDINE; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIAL CELLS; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; LAMININ; MIFEPRISTONE; NEOVASCULARIZATION, PATHOLOGIC; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THROMBOSPONDIN 1; UMBILICAL VEINS;

EID: 79251521493     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014476     Document Type: Article

References (46)

1. Folkman J, Langer R, Linhardt RJ, Haudenschild C, Taylor S (1983) Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science 221(4612): 719-725.
2. Hasan Q, Tan ST, Gush J, Peters SG, Davis PF (2000) Steroid therapy of a proliferating hemangioma: histochemical and molecular changes. Pediatrics 105(1 Pt 1): 117-120.
3. Yano A, Fujii Y, Iwai A, Kageyama Y, Kihara K (2006) Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells. Clinical Cancer Research 12(10): 3003-3009.
4. Hadoke PWF, Iqbal J, Walker BR (2009) Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease. Br J Pharmacol 2009; 156(5): 689-712.
5. Green JP (1965) Steroid Therapy and Wound Healing in Surgical Patients. British Journal of Surgery 52(7): 523.
6. Rae M, Mohamad A, Price D, Hadoke PWF, Walker BR, et al. (2009) Cortisol Inactivation by 11 beta-Hydroxysteroid dehydrogenase-2 May Enhance Endometrial Angiogenesis via Reduced Thrombospondin-1 in Heavy Menstruation. Journal of Clinical Endocrinology & Metabolism 94(4): 1443-1450.
7. Small GR, Hadoke PWF, Sharif I, Dover AR, Armour D, et al. (2005) Preventing local regeneration of glucocorticoids by 11b-hydroxysteroid dehydrogenase type 1 enhances angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 102(34): 12165-12170.
8. Weinstein RS, Wan C, Liu QL, Wang Y, Almeida M, et al. (2010) Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell 9(2): 147-161.
9. Harada I: (1992) The effects of glucocorticoids on angiogenesis in vitro. Nippon Seikeigeka Gakkai Zasshi 66(7): 763-770.
10. Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6(4): 389-395.
11. Berk BC, Vallega G, Griendling KK, Gordon JB, Cragoe EJ, et al. (1988) Effects of glucocorticoids on Na/H exchange and growth in cultured vascular smooth muscle cells. J Cell Physiol 137: 391-401.
12. Longenecker JP, Kilty LA, Johnson LK (1982) Glucocorticoid influence on growth of vascular wall cells in culture. J Cell Physiol 113: 197-202.
13. Longenecker JP, Kilty LA, Johnson LK (1984) Glucocorticoid inhibition of vascular smooth muscle cell proliferation: influence of homologous extracellular matrix and serum mitogens. J Cell Biol 98(2): 534-540.
14. Pross C, Farooq MM, Lane JS, Angle N, Tomono CK, et al. (2002) Rat and human aortic smooth muscle cells display differing migration and matrix metalloproteinase activities in response to dexamethasone. J Vasc Surg 35(6): 1253-1259.
15. Oberleithner H, Schneider SW, Albermann L, Hillebrand U, Ludwig T, et al. (2003) Endothelial cell swelling by aldosterone. J Membr Biol 196(3): 163-172.
16. Yang S, Zhang L (2004) Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2(1): 1-12.
17. Blei F, Wilson EL, Mignatti P, Rifkin DB (1993) Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J Cell Physiol 155(3): 568-578.
18. Stokes C, Weisz P, Williams S, Lauffenburger D (1990) Inhibition of microvascular endothelial cell migrationby b-cyclodextrin tetredecasulphate and hydrocortisone. Microvasc Res 40: 279-284.
19. Morales DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, et al. (1995) Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 91(3): 755-763.
20. Wilasrusmee C, Da SM, Singh B, Siddiqui J, Bruch D, et al. (2003) Morphological and biochemical effects of immunosuppressive drugs in a capillary tube assay for endothelial dysfunction. Clin Transplant 17 Suppl 9: 6-12.
21. Bussolati B, Dunk C, Grohman M, Kontos CD, Mason J, et al. (2001) Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol 159(3): 993-1008.
22. McHugh B, Krause SA, Yu B, Deans AM, Heasman S, et al. (2004) Invadolysin: a novel, conserved metalloprotease links mitotic structural rearrangements with cell migration. J Cell Biol 167(4): 673-686.
23. Christy C, Hadoke PWF, Paterson JM, Mullins JJ, Seckl JR, et al. (2003) Glucocorticoid action in mouse aorta; localisation of 11b Hydroxysteroid dehydrogenase type 2 and effects on response to glucocorticoid in vitro. Hypertension 42(4): 580-587.
24. Boyden S (1962) The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med 115: 453-466.
25. Nauck M, Karakiulakis G, Perruchoud AP, Papakonstantinou E, Roth M (1998) Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 341(2-3): 309-315.
26. Gille J, Reisinger K, Westphal-Varghese B, Kaufmann R (2001) Decreased mRNA stability as a mechanism of glucocorticoid-mediated inhibition of vascular endothelial growth factor gene expression by cultured keratinocytes. J Invest Dermatol 117(6): 1581-1587.
27. Pufe T, Scholz-Ahrens KE, Franke ATM, Petersen W, Wentlein R, et al. (2003) The role of vascular endothelial growth factor in glucocorticoid-induced bone loss: evaluation in a minipig model. Bone 33(6): 869-876.
28. Wen FQ, Liu X, Manda W, Terasaki Y, Kobayashi T, et al. (2003) TH2 Cytokine-enhanced and TGF-beta-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFNc and corticosteroids. J Allergy Clin Immunol 111(6): 1307-1318.
29. Colville-Nash PR, Scott DL (1992) Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann Rheum Dis 51(7): 919-925.
30. Tamura M, Sebastian S, Gurates B, Yang S, Fang Z, et al. (2002) Vascular endothelial growth factor up-regulates cyclooxygenase-2 expression in human endothelial cells. J Clin Endocrinol Metab 87(7): 3504-3507.
31. Luo JC, Shin VY, Liu ES, Ye YN, Wu WK, et al. (2004) Dexamethasone delays ulcer healing by inhibition of angiogenesis in rat stomachs. European Journal of Pharmacology 485(1-3): 275-281.
32. Meadows KN, Bryant P, Pumiglia K (2001) Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation. Journal of Biological Chemistry 276(52): 49289-49298.
33. Rao R, Redha R, Macias-Perez I, Su Y, Hao C, et al. (2007) Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo. Journal of Biological Chemistry 282(23): 16959-16968.
34. Matsuda S, Gomi F, Oshima Y, Tohyama M, Tano Y (2005) Vascular endothelial growth factor reduced and connective tissue growth factor induced by triamcinolone in ARPE19 cells under oxidative stress. Invest Ophthalmol Vis Sci 46(3): 1062-1068.
35. Wang YS, Friedrichs U, Eichler W, Hoffmann S, Wiedemann P (2002) Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells. Graefes Arch Clin Exp Ophthalmol 240(1): 42-48.
36. Oberleithner H, Schneider SW, Albermann L, Hillebrand U, Ludwig T, et al. (2003) Endothelial cell swelling by aldosterone. J Membr Biol 196(3): 163-172.
37. Yang S, Zhang L (2004) Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2(1): 1-12.
38. Nakatsu MN, Sainson RC, Aoto JN, Taylor KL, Aitkenhead M, et al. (2003) Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1. Microvascular Research 66(2): 102-112.
39. Stitt AW, McGoldrick C, Rice-McCaldin A, McCance DR, Glenn JV, et al. (2005) Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3. Diabetes 54(3): 785-794.
40. Blei F, Wilson EL, Mignatti P, Rifkin DB (1993) Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J Cell Physiol 155(3): 568-578.
41. Kräling BM, Wiederschain DG, Boehm T, Rehn M, Mulliken JB, et al. (1999) The role of matrix metalloproteinase activity in the maturation of human capillary endothelial cells in vitro. J Cell Sci 112(Pt 10): 1599-1609.
42. Banciu M, Schiffelers RM, Fens MH, Metselaar JM, Storm G (2006) Intiangiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice. J Control Release 113(1): 1-8.
43. Zou Y, Xu X, Chiou GC (2006) Effect of interleukin-1 blockers, CK112, and CK116 on rat experimental choroidal neovascularization in vivo and endothelial cell cultures in vitro. J Ocul Pharmacol Ther 22(1): 19-25.
44. Chen WL, Lin CT, Yao CC, Huang YH, Chou YB, et al. (2006) In vitro effects of dexamethasone on cellular proliferation, apoptosis, and Na+-K+-ATPase activity of bovine corneal endothelial cells. Ocul Immunol Inflamm 2006;14(4):215-223.
45. Machein MR, Kullmer J, Ronicke V, Machein U, Krieg M, et al. (1999) Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells. Neuropathol Appl Neurobiol 25(2): 104-112.
46. Folkman J, Ingber DE (1987) Angiostatic steroids. Method of discovery and mechanism of action. Ann Surg 206(3): 374-383.